Sat, Apr 19, 2014, 8:09 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Incyte Corporation Message Board

  • medxwatcher medxwatcher Sep 26, 2013 5:56 PM Flag

    INCB 039110 Looks like it could become a blockbuster

    Data from abstracts courtesy of BoAML. This is really exciting folks, and should propel the share price to new highs shortly.

    Table 1:Efficacy profile for JAK inhibitors and anti-TNFs in RA
    ACR20 ACR50 ACR70
    INCB-039110 day 84 (~12wks)
    100mg BID (n=8) 50% 38% 25%
    300mg QD (n=9) 44% 44% 22%
    200mg BID (n=8) 50% 38% 13%
    600mg QD (n=7) 100% 71% 57%
    Placebo (n=8) 38% 25% 13%
    Phase 2b baricitinib 24 weeks
    2mg baricitinib (n=52) 63% 20% 10%
    4mg baricitinib (n=50) 78% 48% 28%
    8mg baricitinib (n=50) 73% 55% 24%
    Phase 2b baricitinib 24 weeks 71% 41% 21%
    Phase 2b baricitinib 52 weeks extension 71% 49% 27%
    ORAL SYNC tofacitinib 24 weeks
    5mg tofacitinib (n=315) 53% 34% 16%
    10mg tofacitinib (n=318) 58% 37% 13%
    Placebo 31% 13% 3%
    ORAL STANDARD tofacitinib 24 weeks
    5mg tofacitinib (n=204) 52% 37% 20%
    10mg tofacitinib (n=201) 53% 35% 22%
    Placebo (n=108) 28% 12% 2%
    Phase 2a VX509 12 weeks
    25mg VX509 (n=41) 39% 17% 7%
    50mg VX509 (n=41) 61% 32% 12%
    100mg VX509 (n=40) 65% 38% 18%
    150mg VX509 (n=41) 66% 49% 22%
    Placebo (n=41) 29% 7% 2%
    Phase 2a GLPG0634 28 days
    '634 100mg 2x/day (n=12) 92% NA NA
    '634 200mg 1x/day (n=12) 75% NA NA
    Placebo (n=12) 33% NA NA
    Phase 2a GLPG0634 28 days
    '634 30mg 1x/day (n=17) 35% 12% NA
    '634 75mg 1x/day (n=22) 55% 28% NA
    '634 150mg 1x/day (n=15) 40% 1% NA
    '634 300mg 1x/day (n=20) 65% 45% NA
    Placebo (n=17) 41% 6% NA
    Biologics 24 weeks
    Humira (ABT) 46% 22% 12%
    Humira (ABT) 53% 35% 18%
    Enbrel (AMGN) 59% 40% 15%
    Simponi (JNJ/MRK) 60% 37% 20%
    Remicade (JNJ/MRK) 50% 28% 10%
    Cimzia (UCB) 59% 37% 21%

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INCY
44.54+0.56(+1.27%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST